Developing medicines for the treatment of severe diseases

Vivoryon Therapeutics N.V. is a biotechnology company developing innovative, orally available small molecule drugs for various indications such as Alzheimer’s disease, inflammatory and fibrotic diseases and cancer, with the goal of improving the lives of critically ill patients through scientific innovation.